Clear Creek Financial Management, LLC Tg Therapeutics, Inc. Transaction History

Clear Creek Financial Management, LLC

  • $854 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$13.32 - $19.19 $13,320 - $19,190
-1,000 Reduced 5.04%
18,850 $335,000
Q1 2024

Apr 26, 2024
BUY
$13.02 - $21.3 $6,510 - $10,650
500 Added 2.58%
19,850 $301,000
Q4 2023

Jan 23, 2024
SELL
$6.68 - $18.81 $5,010 - $14,107
-750 Reduced 3.73%
19,350 $330,000
Q3 2023

Oct 23, 2023
BUY
$8.36 - $26.5 $168,036 - $532,650
20,100 New
20,100 $168,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Clear Creek Financial Management, LLC Portfolio

Follow Clear Creek Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Creek Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Creek Financial Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email